Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
UaBaJKEbWXmmCdGz